Skip to search formSkip to main contentSkip to account menu

Extensively Drug Resistance Process

Known as: EXTENSIVE DRUG RESISTANCE, XDR 
Resistance to nearly all known drugs, particularly the most efficacious or non-first line drugs, used in the treatment of a particular disease.
National Institutes of Health

Related topics

Related topics

3 relations
CDISC SDTM Drug Resistance Status TerminologyClinical Data Interchange Standards Consortium TerminologyPharmacologic Substance

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Integron-Mediated Antibiotic Resistance in Acinetobacter baumannii Isolated from Intensive Care Unit Patients, Babol, North of Iran
Background We investigated the integron types and their relation with antibiotic resistance among A. baumannii isolates collected… 
Highly Cited
2014
Highly Cited
2014
Colistin nephrotoxicity increases with age
Abstract Background: Colistin (COL) has become the backbone of the treatment of infections due to extensively drug-resistant (XDR… 
2014
2014
Effectiveness of infection prevention measures featuring advanced source control and environmental cleaning to limit transmission of extremely-drug resistant Acinetobacter baumannii in a Thai…
2013
2013
From multidrug-resistant to extensively drug-resistant tuberculosis in Lisbon, Portugal: the stepwise mode of resistance acquisition.
OBJECTIVES The development and transmission of extensively drug-resistant (XDR) tuberculosis (TB) constitutes a serious threat to… 
Highly Cited
2012
Highly Cited
2012
SUBMILLIMETER LINE SPECTRUM OF THE SEYFERT GALAXY NGC 1068 FROM THE HERSCHEL-SPIRE FOURIER TRANSFORM SPECTROMETER
The first complete submillimeter spectrum (190–670 μm) of the Seyfert 2 galaxy NGC 1068 has been observed with the SPIRE Fourier… 
2012
2012
Evaluation of polymer carriers with regard to the bioavailability enhancement of bifendate solid dispersions prepared by hot-melt extrusion
Objective: The aim of this study was to evaluate several polymer carriers with regard to the bioavailability enhancement of… 
Highly Cited
2011
Highly Cited
2011
Effective Antibiotics in Combination against Extreme Drug-Resistant Pseudomonas aeruginosa with Decreased Susceptibility to Polymyxin B
Objective Extreme drug-resistant Pseudomonas aeruginosa (XDR-PA) with decreased susceptibility to polymyxin B (PB) has emerged in… 
2011
2011
Safety and efficacy of thioridazine as salvage therapy in Indian patients with XDR-TB.
New drugs are desperately needed to combat XDR-TB as effective treatment involves at least four drugs to which the patient is… 
2009
2009
Resistance to pyrazinamide and ethambutol compromises MDR/XDR-TB treatment.
The rising number of multi-drug resistant tuberculosis (MDR-TB) cases worldwide prompted the World Health Organisation (WHO) to… 
2009
2009
SILA 421, an inhibitor of efflux pumps of cancer cells, enhances the killing of intracellular extensively drug-resistant tuberculosis (XDR-TB).
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)